Loading interface...

Utroprost Tablet

Manufactured byJAGSONPAL PHARMACEUTICALS LTD
ContainsDinoprostone
Description

Utroprost Tablet is a chemical substance that naturally occurs in the body. It is used as a vaginal preparation which helps the pregnant women to prepare for labor by opening their cervix and uterine contraction. It is also used in miscarried women to expel out the remnants of the fetus from the uterus and also for abortion.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Side effects

Major & minor side effects for Utroprost Tablet

  • Nausea and vomiting
  • Diarrhea
  • Abdominal cramps
  • Fever
  • Constipation
  • Swelling of genital area
  • Shortness of breath

Uses of Utroprost Tablet

What is it prescribed for?

  • Induction of labor
  • Termination of pregnancy
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 10 minutes after vaginal insertion in first and second trimester pregnancies.
  • How long do the effects of this medicine last?
    The effects of this medicine last up to 2-3 hours after vaginal insertion.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    Use of this medicine is not recommended for pregnant women other than for the indicated uses such as the induction of labor and termination of pregnancy. Otherwise, the risk of birth defects, abortion, and other abnormalities are very high.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Dinoprostone or any other inactive ingredients present in the formulation.

Cesarean section

This medicine is not recommended for patients who have a history of cesarean section due to the increased risk of adverse effects.

Grand multiparae

This medicine is not recommended for use in patients with a history of 6 or more term pregnancies due to the increased risk of worsening of the patient's condition.

Acute Pelvic Inflammatory Disease

This suppository form of this medicine is not recommended for use in patients with acute pelvic inflammatory disease due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

Use of this medicine is not recommended for pregnant women other than for the indicated uses such as the induction of labor and termination of pregnancy. Otherwise, the risk of birth defects, abortion, and other abnormalities are very high.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Use with Caution

This medicine should be used with caution in patients with epilepsy, glaucoma, hepatic/renal impairment, pulmonary disease.

Uterine rupture

This medicine has been associated with cases of uterine rupture when used for labor induction in some cases. Caution is advised while using this medicine if the patient is in the late thirties and beyond or the delivery is cesarean.

For hospital use only

This medicine should be administered only by trained obstetrical personnel in a hospital setting with appropriate obstetrical care facilities.

Missed Dose

Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Misoprostol

Mifepristone

Oxytocin

Ergonovine

Disease interactions

Asthma

This medicine should be used with caution in patients with asthma due to the increased risk of bronchospasm, decreased pulmonary blood flow, and/or increased pulmonary arterial pressure. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hypotension

This medicine should be used with caution in patients with decreased blood pressure due to the increased risk of adverse effects. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine should be administered only by trained obstetrical personnel in a hospital setting with appropriate obstetrical care facilities. Detect whether the patient is allergic to this medicine or any other prostaglandin analogs before initiating the treatment.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by opening the cervix and inducing uterine contractions during labor.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Uterotonic agents

Schedule

Schedule H

[Internet]. Dailymed.nlm.nih.gov. 2019 [cited 3 January 2019]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3bc9031-0620-4a50-b440-f661cadfeb1d

Dinoprostone - DrugBank [Internet]. Drugbank.ca. 2019 [cited 3 January 2019]. Available from:

https://www.drugbank.ca/drugs/DB00917

[Internet]. Medicines.org.uk. 2019 [cited 3 January 2019]. Available from:

https://www.medicines.org.uk/emc/product/135/smpc#PHARMACOKINETIC_PROPS

[Internet]. Ebs.tga.gov.au. 2019 [cited 3 January 2019]. Available from:

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05404-3
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 21 Aug 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.